Skip to main content
. 2011 Jan 20;11:5. doi: 10.1186/1471-2466-11-5

Table 2.

Overall adherence with tobramycin inhalation solution by P. aeruginosa infection.

Low utilization ≤2 cycles (n = 570) Medium utilization >2 to <4 cycles (n = 180) High utilization ≥4 cycles (n = 54)
All (N = 804) 71% 22% 7%
With P. aeruginosa (n = 452) 72% 22% 6%
Without P. aeruginosa (n = 352) 70% 23% 7%